HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Crystal structure of human wildtype and S581L-mutant glycyl-tRNA synthetase, an enzyme underlying distal spinal muscular atrophy.

Abstract
Dominant mutations in the ubiquitous enzyme glycyl-tRNA synthetase (GlyRS), including S581L, lead to motor nerve degeneration. We have determined crystal structures of wildtype and S581L-mutant human GlyRS. The S581L mutation is approximately 50A from the active site, and yet gives reduced aminoacylation activity. The overall structures of wildtype and S581L-GlyRS, including the active site, are very similar. However, residues 567-575 of the anticodon-binding domain shift position and in turn could indirectly affect glycine binding via the tRNA or alternatively inhibit conformational changes. Reduced enzyme activity may underlie neuronal degeneration, although a dominant-negative effect is more likely in this autosomal dominant disorder.
AuthorsMuhammed Z Cader, Jingshan Ren, Paul A James, Louise E Bird, Kevin Talbot, David K Stammers
JournalFEBS letters (FEBS Lett) Vol. 581 Issue 16 Pg. 2959-64 (Jun 26 2007) ISSN: 0014-5793 [Print] England
PMID17544401 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Mutant Proteins
  • RNA-Binding Proteins
  • Serine
  • Glycine-tRNA Ligase
  • Leucine
Topics
  • Amino Acid Substitution
  • Binding Sites
  • Crystallography, X-Ray
  • Dimerization
  • Distal Myopathies (enzymology, genetics)
  • Glycine-tRNA Ligase (chemistry, genetics, metabolism)
  • Humans
  • Leucine (chemistry)
  • Models, Molecular
  • Muscular Atrophy, Spinal (enzymology, genetics)
  • Mutant Proteins (chemistry, metabolism)
  • Mutation, Missense
  • RNA-Binding Proteins (chemistry, metabolism)
  • Serine (chemistry)
  • Transfer RNA Aminoacylation (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: